RightFit
RecruitingNot applicable

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
25 Years and older
Sex
Female only
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "AIM 3: Participants attend interviews or workshop discussions on study."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests an updated family health history program for women who have received care at rural public health clinics in Southwest Georgia. It aims to help more women get their cancer risk checked and access genetic counseling and testing for BRCA-related cancers. BRCA genes can have changes that raise cancer risk.

This clinical trial adapts and evaluates the effectiveness of a family history screening program (GA CORE) for increasing uptake of genetic screening for BRCA-associated cancers in women who have received care in rural public health clinics in Southwest Georgia. Brief and low-cost family history-based screening assessments to identify families at high risk for BRCA-associated cancers have been endorsed by national guidelines and public health organizations. Georgia is among the few states to have implemented statewide family history screening for BRCA-associated cancers. Despite its potential, current clinic-based approaches that identify at-risk women are not sustainable and show limited reach. Additionally, uptake of follow-up cancer screening is sub-optimal and solely focuses on women screened as high genetic risk. This trial will adapt the existing family history screening program and then evaluate it's effectiveness for increasing the number and diversity of women who receive a history assessment and subsequent access to risk-based services such as genetic counseling and testing.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Main study (Aim 2): Women age 25 or older who can read English and have ever received care in the Women's Health Section at a participating Southwest district public health clinic.
  • Advisory group: State cancer control leaders, public health district leaders or staff, and women age 25 or older who receive care in the Southwest district.
  • Discussion forum: English-speaking women age 25 or older who completed family history screening in the project's first 3 months at one of the 14 Southwest district clinics.
  • Clinic staff interviews: Medical directors, nurses, and clinic staff at the 14 Southwest district clinics.
  • Follow-up interviews: Women from Aim 2, whether or not they completed the recommended genetic services.
  • Workshop: Medical and office leaders, nurses, and clinic staff from the six participating clinic sites.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: * AIM 1 STAKEHOLDER ADVISORY COMMITTEE: 10 stakeholders representing three constituencies: state cancer control leaders (n=2), participating public health district champions (n=4) (i.e., administrative directors, nurses, clinic staff) and patients (n=4) (i.e., women, age 25 and older who receive their care in the Southwest district) * AIM 1 DISCUSSION FORUM: 25 years or older * AIM 1 DISCUSSION FORUM: Women * AIM 1 DISCUSSION FORUM: English-speaker * AIM 1 DISCUSSION FORUM: Have completed family history screening during the first 3 months of the project at one of 14 public health clinics in Southwest district * AIM 1 ORGANIZATIONAL STAKEHOLDER INTERVIEW: Organizational stakeholders (i.e., medical directors, nurses, and clinic staff) at the 14 clinic sites in Southwest district * AIM 2: Women * AIM 2: Ages 25 and older * AIM 2: Who can read English * AIM 2: Have ever been seen in Women's Health Section through one of participating public health clinics in Southwest district * AIM 3 POST-INTERVENTION INTERVIEW: Participants from aim 2, regardless of whether they completed the recommended genetic services or not (e.g. complete telegenetic session or genetic testing) * AIM 3 WORKSHOP DISCUSSION: Medical and administrative directors, nurses, and clinic staff from the six participating clinic sites

    Study sites (1)

    GA